The Critical Role of PPAR𝜸 in Human Malignant Melanoma

Figure 1

Activating pathways known to be constitutively active and contributing to the chemoresistance of melanoma cells. Over 60% of melanomas have activating mutations of B-RAF, 30% have lost PTEN expression, majority with NF-κB activation.